Angela Koehler is the Kathleen and Curtis Marble Professor of Cancer Research in the Department of Biological Engineering at MIT and Associate Director of the Koch Institute for Integrative Cancer Research at MIT. She is the Faculty Director of the MIT Deshpande Center for Technological Innovation, Faculty Director of the Swanson Biotechnology Center, an Institute Member of the Broad Institute, and a Founding Member of the MIT Center for Precision Cancer Medicine. Her research group aims to discover and develop functional small-molecule probes of proteins involved in oncology, including pediatric cancers, as well as inflammatory or autoimmune disorders. Selected probes may be developed into imaging agents, diagnostic tools, or therapeutic leads.

Angela received her B.A. in Biochemistry and Molecular Biology from Reed College in 1997. There she worked under the guidance of Professor Arthur Glasfeld on structural and biochemical studies of proteins that recognize tRNA or DNA. In 2003, she received her Ph.D. in Chemistry from Harvard University where she worked with Professor Stuart Schreiber to develop novel technologies for identifying and characterizing interactions between proteins and small molecules. Upon graduation, she became an Institute Fellow in the Chemical Biology Program at the Broad Institute and a Group Leader for the NCI Initiative for Chemical Genetics.

Angela has served on the Chemists in Cancer Research Executive Advisory Board for AACR and various NCI advisory panels. Awards include being named a Genome Technology Young Investigator and a Broad Institute Merkin Fellow as well as the Novartis Lectureship in Chemistry, the Ono Pharma Breakthrough Science Award, the AACR-Bayer Innovation and Discovery Award and the Junior Bose Award for Excellence in Teaching. Angela serves as a consultant or scientific advisory board member to several pharmaceutical or biotechnology companies and has founded three biotechnology companies.